CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,118 | +22.2% | 17,082 | +30.2% | 0.00% | – |
| Q4 2021 | $32,000 | -67.0% | 13,118 | -34.3% | 0.00% | – |
| Q3 2021 | $97,000 | +34.7% | 19,954 | -24.5% | 0.00% | -100.0% |
| Q2 2020 | $72,000 | +38.5% | 26,418 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $52,000 | -71.7% | 24,436 | -46.6% | 0.00% | -50.0% |
| Q1 2019 | $184,000 | -31.9% | 45,785 | -37.7% | 0.00% | -33.3% |
| Q4 2018 | $270,000 | -38.1% | 73,454 | +44.5% | 0.00% | -40.0% |
| Q3 2018 | $436,000 | +164.2% | 50,824 | +237.6% | 0.01% | +150.0% |
| Q2 2018 | $165,000 | +7.1% | 15,053 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $154,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $4,782,399 | 1.67% |
| TOWERVIEW LLC | 342,478 | $500,018 | 0.33% |
| Orbimed Advisors | 6,943,654 | $10,137,735 | 0.22% |
| SAMLYN CAPITAL, LLC | 2,405,764 | $3,512,415 | 0.06% |
| BVF INC/IL | 1,370,947 | $2,001,583 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $93,109 | 0.04% |
| MYDA Advisors LLC | 68,814 | $100,468 | 0.03% |
| Masso Torrence Wealth Management Inc. | 10,000 | $14,600 | 0.01% |
| Hikari Power Ltd | 49,959 | $73 | 0.01% |
| XTX Topco Ltd | 19,244 | $28,096 | 0.01% |